Entering text into the input field will update the search result below

Baudax Bio wins new U.S. patent for pain therapy

Mar. 02, 2022 7:36 AM ETBaudax Bio, Inc. (BXRX)By: Dulan Lokuwithana, SA News Editor

Patents files folder

oonal/iStock via Getty Images

  • Baudax Bio (NASDAQ:BXRX) has added ~3% in the pre-market Wednesday after the commercial-stage pharmaceutical company announced that the U.S. regulators issued a new patent related to its pain medication, Anjeso.
  • The United States Patent No.11,253,478 covers the

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.